On Friday, Amarin Corporation plc (ADR) (NASDAQ:AMRN)’s shares declined -6.57% to $1.85.
Amarin Corporation plc (ADR) (AMRN) declared financial results for the quarter ended March 31, 2015, and offered an update on company operations.
Key Amarin achievements since December 31, 2014 comprise:
- R&D progress: REDUCE-IT cardiovascular outcomes study, designed to provide data to support a significantly expanded label for Vascepa, continued on plan for a protocol pre-specified interim efficacy look by the independent Data Monitoring Committee (DMC) in 2016 and, if not stopped early, for completion in 2017 and presentation/publication of results in 2018;
- Revenue growth: Recognized $15.6 million in net product revenue from Vascepa sales in Q1 2015 contrast to $11.0 million in Q1 2014, an enhance of 42%;
- Prescription growth: Raised normalized prescriptions, based upon data from Symphony Health Solutions, by 66% in Q1 2015 contrast to Q1 2014;
Amarin Corporation plc, a biopharmaceutical company, focuses on developing and commercializing therapeutics for the treatment of cardiovascular diseases in the United States.
Enphase Energy Inc (NASDAQ:ENPH)’s shares dropped -6.04% to $10.26.
Enphase Energy Inc (ENPH) declared regional Australia has practiced a 453 percent year-over-year growth in installed solar units in 2014, outpacing metropolitan growth at 440 percent for the same period.
Enphase has seen outstanding growth in regional and outback Australia with the enhance in its solar microinverter installations in 2014. These figures align with data from the REC Agents Association, which states that in 2012, 53 percent of solar systems were installed in regional and rural communities contrast to 43 percent in major capital cities.
Enphase Energy, Inc., together with its auxiliaries, designs, develops, and sells microinverter systems for the solar photovoltaic industry in the United States and internationally.
At the end of Friday’s trade, Broadridge Financial Solutions, Inc. (NYSE:BR)‘s shares dipped -5.67% to $51.03.
Broadridge Financial Solutions, Inc. (BR) declared that its Board of Directors has declared a quarterly cash dividend of $0.27 per share. The dividend is payable on July 1, 2015, to stockholders of record at the close of business on June 17, 2015.
Broadridge Financial Solutions, Inc. provides investor communications and technology-driven solutions for the financial services industry in the United States, Canada, the United Kingdom, and internationally.
Discovery Laboratories, Inc. (NASDAQ:DSCO), ended its Friday’s trading session with -5.61% loss, and closed at $1.01.
Discovery Laboratories, Inc. (DSCO) declared financial results for the first quarter ended March 31, 2015.
Key Financial and Business Updates
The Company stated a net loss of $12.2 million ($0.14 per basic share) on 85.6 million weighted-average common shares outstanding for the quarter ended March 31, 2015, contrast to a net loss of $11.5 million ($0.14 per basic share) on 84.7 million weighted average common shares outstanding for the comparable period in 2014. For the quarter ended March 31, 2015, the Company stated an operating loss of $11.2 million contrast to $10.8 million for comparable period in 2014.
Net cash outflows for the quarter ended March 31, 2015 were $9.1 million. As of March 31, 2015, the Company had cash and cash equivalents of $35.6 million.
Discovery Laboratories, Inc., a specialty biotechnology company, focuses on developing products for critical-care patients with respiratory disease and improving care in pulmonary medicine.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
